IL17A and COVID-19: Conversely, during the acute phase of SARS-CoV-2 infection, CD4+ T cells from the lungs of patients with COVID-19 did not increase Th17-associated genes, including RORC, IL17A, and IL17F, and CCR6 expression was significantly reduced in patients with severe COVID-19 [45].